1. Home
  2. ISPR vs CPIX Comparison

ISPR vs CPIX Comparison

Compare ISPR & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ispire Technology Inc.

ISPR

Ispire Technology Inc.

N/A

Current Price

$1.51

Market Cap

85.5M

Sector

Health Care

ML Signal

N/A

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$4.35

Market Cap

98.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ISPR
CPIX
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.5M
98.3M
IPO Year
2023
2007

Fundamental Metrics

Financial Performance
Metric
ISPR
CPIX
Price
$1.51
$4.35
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $4.90
N/A
AVG Volume (30 Days)
11.4K
★ 96.7K
Earning Date
11-17-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
15.94
★ 58.70
EPS
N/A
★ N/A
Revenue
★ $96,014,610.00
$42,010,949.00
Revenue This Year
$16.14
N/A
Revenue Next Year
$8.92
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.75
52 Week Low
$1.01
$1.85
52 Week High
$3.87
$9.28

Technical Indicators

Market Signals
Indicator
ISPR
CPIX
Relative Strength Index (RSI) 51.74 33.14
Support Level $1.33 $3.08
Resistance Level $1.65 $5.03
Average True Range (ATR) 0.09 0.85
MACD 0.01 -0.33
Stochastic Oscillator 54.55 5.02

Price Performance

Historical Comparison
ISPR
CPIX

About ISPR Ispire Technology Inc.

Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: